Individuals with obesity should be counselled to accumulate at least 150 minutes a week of moderate aerobic exercise, such as walking, and to engage in resistance training to preserve lean mass
Many patients notice meaningful improvements in portion control, cravings, and consistency over time
Additionally, the gastrointestinal side effects of tirzepatide (nausea, vomiting, diarrhea) can cause volume depletion leading to low blood pressure, especially in patients taking diuretics or other antihypertensive medications
doi: 10.3389/fphar.2022.932205 59 JungSWMoonJY
EPR measurements were performed at 77 K using the Bruker EMXnano X-band spectrometer
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)